Elizabeth Cohen–Jonathan

Author

Also Known As

E Cohen-Jonathan, E. Cohen-Jonathan, E. Moyal Cohen-Jonathan, Elizabeth Cohen-Jonathan, Elizabeth Cohen‐Jonathan, Elizabeth Cohen–Jonathan, Elizabeth Moyal Cohen-Jonathan, É. Moyal Cohen-Jonathan, É.-M. Cohen-Jonathan

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Institut Claudius Regaud Inserm Université Toulouse III - Paul Sabatier University of Pennsylvania

About

Elizabeth Cohen–Jonathan is an author at Institut Claudius Regaud specializing in medicine, cell biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	512
2	Cell Biology	9	9	512
3	Health Sciences	4	4	225
4	Natural Sciences	2	2	74
5	Cellular Physiology	2	2	134

Elizabeth Cohen–Jonathan

Publications

899

Citations

H-Index

Page 1

	Year	Citations
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost S. Ken, L. Vieillevigne, X. Franceries, Radiation Oncology	2013	229
Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation Caroline Delmas, Christophe Héliez, Elizabeth Cohen–Jonathan, International Journal of Cancer High-grade GliomasRadiation BiologyGliomaTumor BiologyNeuro-oncology	2002	88
Farnesyltransferase Inhibitors Potentiate the Antitumor Effect of Radiation on a Human Tumor Xenograft Expressing Activated HRAS<sup>1</sup> Elizabeth Cohen–Jonathan, Ruth J. Muschel, W. Gillies McKenna, Radiation Research	2000	74
The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft. Caroline Delmas, D End, Philippe Rochaix, PubMed	2003	70
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras. Elizabeth Cohen–Jonathan, Sydney M. Evans, Cameron J. Koch, PubMed Tumor XenograftsCancer BiologyRedox BiologyTumor BiologyOxidative Stress	2001	70
Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells. Elizabeth Cohen–Jonathan, Christine Toulas, S Monteil, PubMed G2 DelayRadiation EffectCell ProliferationHela CellsCell Growth	1997	69
RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death Isabelle Ader, Christine Toulas, Florence Dalenc, Oncogene Signal TransductionHealth SciencesCell DivisionCell RegulationCell Signaling	2002	65
The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunit Isabelle Ader, Catherine Muller, Jacques Bonnet, Oncogene ChromatinSignal TransductionSignaling PathwayReceptor Tyrosine KinaseFibroblast Growth Factor	2002	59
Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts Sophie Pinel, Muriel Barberi‐Heyob, Elizabeth Cohen–Jonathan, International Journal of Radiation OncologyBiologyPhysics Human Glioma XenograftsRadiation TherapyIrradiation ContributesRadiation EffectRadiation Exposure	2004	55
Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls radiation-induced centrosome overduplication Julie Milia, F Teyssier, Florence Dalenc, Cell Death and Differentiation Cell DivisionNatural SciencesRadiation EffectRadiation ExposureMolecular Biology	2005	40

Page 1